Clinical Trial: A risk prediction model for postpartum hemorrhage following prophylactic internal iliac artery balloon occlusion in patients with pernicious placenta previa and placenta accreta: a single-center retrospective study (China)

Posted On: 2026-08-19

China, Aug. 19 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A risk prediction model for postpartum hemorrhage following prophylactic internal iliac artery balloon occlusion in patients with pernicious placenta previa and placenta accreta: a single-center retrospective study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130348

Registration Time: 2026/08/19

Type: Observational study

Primary Sponsor: Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=339031

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: A risk prediction model for postpartum hemorrhage following prophylactic internal iliac artery balloon occlusion in patients with pernicious placenta previa and placenta accreta: a single-center retrospective study (China)